Skip to main content
ACOG logo

ACOG · Alpha Cognition Inc.

Track ACOG — free
$8.84 +0.21 (+2.43%) At close · Aug 14
Market Cap
$192.52M
Shares
21.78M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$8.84 Open$9.34 Day$8.20–9.50 52W close$4.50–9.80 Avg vol 30d101K Short int185K · 0.8% float · 1.5d Short vol27% Last earningsMar 31, 2026 DataNov 2024–Aug 2026 Filing10-Q · Aug 13

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Aug 13, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Buy
      SellHoldBuy
      Technical Buy Momentum Very Strong Sentiment Bullish Fundamentals Strong Quant / Vol Very High
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +39%
      above
      Price vs 50-day avg +15%
      above
      RSI (14) 57
      neutral
      MACD trend Negative
      52-week position 82%
      mid-range
      Momentum
      relative strength
      Very Strong
      1-month return +4%
      trailing
      6-month return +50%
      trailing
      YTD return +36%
      this year
      Relative strength +36%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bullish
      Trend (MA cross) No cross
      50d $8 › 200d $6 — 50d above 200d
      Institutional flow Flat
      0% holders QoQ · +1 funds added
      Insider flow Accumulating
      Net +$3.8M over 90 days · 0% sells
      Short interest Falling
      0.85% of float · ▼ -14.4% MoM · 1.5 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      25 holders — mid 1-yr range
      Squeeze score 46
      elevated · 0–100
      Fundamentals
      Strong
      EPS growth +42%
      Y/Y
      Free cash flow $-20.7M
      Balance sheet $65.1M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 67%
      annualized · 1-yr
      Max drawdown −54%
      past year
      ATR 8.1%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the Earnings Call filed Mar 31, 2026
      Full year 2026 operating expense · full year 2026 $54M – $58M
      Prior guidance period ended · from the Earnings Call filed Sep 30, 2025
      Operating expenses · full year 2025 $28M – $30M

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      1 · 3 · 2
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +39% Bullish
      Price vs 50-day avg
      +15% Bullish
      RSI (14)
      57 Neutral
      MACD trend
      Negative Bearish
      52-week position
      82% Neutral
      Market signals — smart money & positioning
      Bullish · 2 of 6
      Trend (MA cross) No cross
      50d $8 › 200d $6 — 50d above 200d
      Institutional flow Flat
      0% holders QoQ · +1 funds added
      Insider flow Accumulating
      Net +$3.8M over 90 days · 0% sells
      Short interest Falling
      0.85% of float · ▼ -14.4% MoM · 1.5 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      25 holders — mid 1-yr range
      Price context
      position in its 52-week range
      Range low $5 Now $9 · 82% Range high $10
      vs 200-day avg +39% vs 50-day avg +15%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Bottles Dispensed 4,941 Q4 2025
      Bottles sold in December 1,859 December 2025
      Cumulative homes with prescriptions Q4 growth 26% Q4 2025
      Cumulative unique facilities engaged since launch 4,000 since commercial launch through Q4 2025
      Homes reached by sales team 1,986 Q4 2025
      Q4 bottles dispensed quarter-over-quarter growth 62% Q4 2025
      Q4 prescribers quarter-over-quarter growth 50% Q4 2025

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Biotechnology — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      ACOG
      Alpha Cognition Inc.
      this stock
      $192.52M +36.0% 0.8%
      ONC
      BeOne Medicines Ltd.
      $513.62B +14.4% +22179.2% 789.7 0.1%
      VRTX
      Vertex Pharmaceuticals Inc / Ma
      $128.19B +11.6% +46.2% 29.5 1.6%
      REGN
      Regeneron Pharmaceuticals, Inc.
      $82.72B +4.1% +20.8% 19.9 3.3%
      ARGX
      Argenx SE
      $52.94B +1.2% 2.1%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Reducing
      Holders
      25
      % held
      48.1%
      Net QoQ
      -63.3K sh
      Top holder
      Opaleye Management Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      1
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      184.6K
      Days to cover
      1.5d
      Change
      -31.0K sh
      View
      Short Volume
      Short vol %
      27%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      371
      Value
      $3.2K
      As of
      Jul 10, 2026
      View
      Off-Exchange
      Off-exchange %
      56.2%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net buying
      Net (90d)
      +$3.8M
      Buyers / Sellers
      2 / 0
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $10.2M
      Net income (FY)
      $-20.7M
      EPS diluted
      $-1.18
      View
      Filings
      SEC Filings
      Latest
      10-Q
      Filed
      Aug 13, 2026
      This year
      12
      View
      Exempt Offerings
      Offering
      $346.9K
      Filed
      Nov 18, 2024
      View
      Earnings & Events
      Earnings Calls
      Last call
      Mar 31, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      ACOG -3.2% +4.0% +50.1% +6.8% +36.0%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY -3.6% -0.5% +36.3% +2.8% +22.2%
      Key facts CIK 1655923 CUSIP 02074J501 13F (30d) 26 filings 25 filers Visit website Investor relations